Date published: 2026-6-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

L-CCG-IV (CAS 117857-95-1)

0.0(0)
Write a reviewAsk a question

Alternate Names:
(2S,1′S,2′R)-2-(Carboxycyclopropyl)glycine
Application:
L-CCG-IV is a potent small molecule agonist at the NMDA receptor
CAS Number:
117857-95-1
Purity:
≥97%
Molecular Weight:
159.14
Molecular Formula:
C6H9NO4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

L-CCG-IV is a potent NMDA receptor agonist.


L-CCG-IV (CAS 117857-95-1) References

  1. Evaluation and comparison of ion permeation and agonist selectivities for N-methyl-d-aspartate receptor channels with different subunit compositions in bilayer lipid membranes based on integrated single-channel currents.  |  Hirano, A., et al. 2000. Anal Biochem. 283: 258-65. PMID: 10906247
  2. A single-channel method for evaluation of very magnitudes of Ca2+ ion fluxes through epsilon4/zeta1 N-methyl-D-aspartate receptor channels in bilayer lipid membranes.  |  Wakabayashi, M., et al. 2001. J Pharm Biomed Anal. 24: 453-60. PMID: 11199224
  3. 2-(Carboxycyclopropyl)glycines: binding, neurotoxicity and induction of intracellular free Ca2+ increase.  |  Kawai, M., et al. 1992. Eur J Pharmacol. 211: 195-202. PMID: 1319341
  4. Changes in preference for receptor subtypes of configurational variants of a glutamate analog: conversion from the NMDA-type to the non-NMDA type.  |  Ishida, M., et al. 1991. Brain Res. 550: 152-6. PMID: 1653635
  5. A significant increase in intracellular Ca2+ concentration induced by (2S,3R,4S)-2-(carboxycyclopropyl)glycine, a new potent NMDA agonist, in cultured rat hippocampal neurons.  |  Kudo, Y., et al. 1991. Brain Res. 567: 342-5. PMID: 1840131
  6. Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors.  |  Vance, KM., et al. 2011. Nat Commun. 2: 294. PMID: 21522138
  7. A conformationally restricted analogue of L-glutamate, the (2S,3R,4S) isomer of L-alpha-(carboxycyclopropyl)glycine, activates the NMDA-type receptor more markedly than NMDA in the isolated rat spinal cord.  |  Shinozaki, H., et al. 1989. Brain Res. 480: 355-9. PMID: 2565750
  8. Potent NMDA-like actions and potentiation of glutamate responses by conformational variants of a glutamate analogue in the rat spinal cord.  |  Shinozaki, H., et al. 1989. Br J Pharmacol. 98: 1213-24. PMID: 2692753
  9. Metabotropic glutamate receptor agonist DCG-IV as NMDA receptor agonist in immature rat hippocampal neurons.  |  Wilsch, VW., et al. 1994. Eur J Pharmacol. 262: 287-91. PMID: 7813594
  10. (2S,3S,4R)-2-(carboxycyclopropyl)glycine, a potent and competitive inhibitor of both glial and neuronal uptake of glutamate.  |  Nakamura, Y., et al. 1993. Neuropharmacology. 32: 833-7. PMID: 7901789
  11. A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord.  |  Ishida, M., et al. 1993. Br J Pharmacol. 109: 1169-77. PMID: 8401927
  12. DCG-IV, a potent metabotropic glutamate receptor agonist, as an NMDA receptor agonist in the rat cortical slice.  |  Uyama, Y., et al. 1997. Brain Res. 752: 327-30. PMID: 9106476

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

L-CCG-IV, 1 mg

sc-203098
1 mg
$213.00